Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME: Stem Cell Timing in Acute MI
NCT00684021Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jul 2008
- Primary completion
- May 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bone marrow mononuclear cells in acute myocardial infarction (AMI) and left ventricular dysfunction (4 arms), sponsored by UTHealth Houston. Primary endpoints: Global Left Ventricular Function at 6 months and Regional Left Ventricular Function (Infarct and Border Zone Wall Motion) at 6 months. Started Jul 2008; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
acute myocardial infarction (AMI)left ventricular dysfunction
Beyond the preview
Go deeper on NCT00684021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684021.